Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV.

Sinkala M, Stout JP, Vermund SH, Goldenberg RL, Stringer JS
Lancet. 2001 358 (9293): 1611-2

PMID: 11716891 · DOI:10.1016/S0140-6736(01)06662-4

Use of mass nevirapine therapy--universal provision of the drug without HIV testing--for prevention of perinatal HIV in high prevalence settings with extreme resource constraints is a controversial strategy. A quarter of pregnant Zambian women surveyed would prefer to receive nevirapine through a non-testing mass strategy, and most would support mass therapy as a policy if it would make the drug available to a larger proportion of the at-risk population.

MeSH Terms (10)

Anti-HIV Agents Attitude to Health Female HIV Infections Humans Infectious Disease Transmission, Vertical Nevirapine Pregnancy Surveys and Questionnaires Zambia

Connections (1)

This publication is referenced by other Labnodes entities: